Home › Funds › Dana Investment Advisors, Inc. › LGND

Dana Investment Advisors, Inc. position in LGND

LIGAND PHARMACEUTICALS INC · Health Care

Dana Investment Advisors, Inc. reported holding 54,302 shares of LGND (LIGAND PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$17.0M, representing 0.45% of its reported portfolio and ranking #44 among its reported holdings. Dana Investment Advisors, Inc. has disclosed LGND holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)54.30K sh
Reported value held$16.96M
Portfolio Weight0.45%
First reportedQ1 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Dana Investment Advisors, Inc.'s LGND position evolved

Dana Investment Advisors, Inc. first disclosed a stake in LGND in Q1 2024 at 75,846 shares (US$5.5M). The position peaked in Q2 2026 at 57,520 shares, worth US$18.2M. Across 11 filings, Dana Investment Advisors, Inc. increased the stake 1 time(s), trimmed it 8 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 54,302 shares valued at US$17.0M — a reduction of -3,218 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2024 75.85K $5.54M New
Q2 2024 90.06K $7.59M Add
Q3 2024 80.60K $8.07M Reduce
Q4 2024 76.23K $8.17M Reduce
Q1 2025 74.31K $7.81M Reduce
Q2 2025 73.17K $8.32M Reduce
Q3 2025 72.66K $12.87M Reduce
Q4 2025 69.40K $13.12M Reduce
Q1 2026 69.23K $13.82M Hold
Q2 2026 57.52K $18.18M Reduce
Q3 2026 54.30K $16.96M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LGND and 13F data

LGND (LIGAND PHARMACEUTICALS INC) is a Health Care company. 52 other funds we track also report a position in LGND — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$205.7M), Chicago Capital, LLC (US$172.2M), Stephens Investment Management Group LLC (US$139.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LGND

All LGND fund holders →

FAQ

How long has Dana Investment Advisors, Inc. held LGND?

Dana Investment Advisors, Inc. has disclosed LGND holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is Dana Investment Advisors, Inc.'s current position in LGND?

As of Q3 2026, Dana Investment Advisors, Inc. holds 54.30K shares of LGND (LIGAND PHARMACEUTICALS INC), valued at $16.96M, representing 0.45% of its reported portfolio and ranking #44.

Has Dana Investment Advisors, Inc. been buying or selling LGND?

In the latest 13F filing (Q3 2026), Dana Investment Advisors, Inc. reduced its position in LGND. The position peaked in Q2 2026 at 57.52K shares.

Which other funds hold LGND?

Other major institutional holders of LGND include CONGRESS ASSET MANAGEMENT CO, Chicago Capital, LLC, Stephens Investment Management Group LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.